Published in PLoS One on February 07, 2013
A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder. Transl Psychiatry (2015) 0.78
What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders? Mol Neuropsychiatry (2015) 0.75
Correlation between protein and mRNA abundance in yeast. Mol Cell Biol (1999) 16.95
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Subgenual prefrontal cortex abnormalities in mood disorders. Nature (1997) 9.36
Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol (2003) 6.98
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry (2001) 2.69
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Mitochondrial dysfunction in bipolar disorder. Bipolar Disord (2000) 2.32
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res (2010) 2.04
A Danish twin study of manic-depressive disorders. Br J Psychiatry (1977) 1.86
Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci (2012) 1.80
Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol Psychiatry (2007) 1.74
Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics (2006) 1.73
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem (2001) 1.73
Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry (2000) 1.71
Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry (2010) 1.53
Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry (2000) 1.53
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet (2003) 1.46
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci (2010) 1.44
Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord (2002) 1.41
2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics (2009) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry (2000) 1.38
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry (2007) 1.32
The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry (2006) 1.28
Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry (1965) 1.24
Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry (2007) 1.21
Structure of yeast phosphoglycerate mutase. Nature (1974) 1.16
Post-mortem interval effects on the phosphorylation of signaling proteins. Neuropsychopharmacology (2003) 1.13
The neuroproteomics of schizophrenia. Biol Psychiatry (2011) 1.11
Serotonergic dysfunction in depression. Br J Psychiatry Suppl (1989) 1.11
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother (2008) 1.09
Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci (2009) 1.07
The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Br J Pharmacol (2008) 1.05
PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry (2002) 1.03
Postmortem changes in the level of brain proteins. Exp Neurol (2001) 1.00
Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics (2010) 0.99
Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol Psychiatry (2005) 0.98
Glycogen metabolism and glycolytic enzymes. Annu Rev Biochem (1970) 0.96
Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol Dis (2006) 0.94
Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol (2003) 0.91
Dihydropyrimidinase related protein-2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome. Proteomics (2003) 0.91
Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Transl Psychiatry (2011) 0.89
Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression. Brain Res (2008) 0.87
Twin studies of affective illness. Arch Gen Psychiatry (1976) 0.86
Proteomic approaches in brain research and neuropharmacology. Eur J Pharmacol (2004) 0.81
Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics (2010) 0.78
Lithium chloride alters cytoskeletal organization in growing, but not mature, cultured chick sensory neurons. J Neurosci Res (1991) 0.78
Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. Life Sci (2002) 0.76
Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02
Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell (2009) 3.45
Nutritional biochemistry: A new redox-cofactor vitamin for mammals. Nature (2003) 2.97
Infant calming responses during maternal carrying in humans and mice. Curr Biol (2013) 2.35
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet (2012) 2.31
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet (2008) 2.09
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Appropriate data cleaning methods for genome-wide association study. J Hum Genet (2008) 1.92
Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci (2012) 1.80
Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet (2006) 1.78
Serum cholesterol, uric acid and cholinesterase in victims of the Tokyo subway sarin poisoning: a relation with post-traumatic stress disorder. Neurosci Res (2002) 1.73
Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res (2011) 1.61
Study of an economic issue as a possible indicator of suicide risk: a discussion of stock prices and suicide. J Forensic Sci (2012) 1.51
DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci (2005) 1.49
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet (2003) 1.46
Neuroimaging-aided differential diagnosis of the depressive state. Neuroimage (2013) 1.38
Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res (2007) 1.30
Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology (2008) 1.29
RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett (2003) 1.26
Detection of chromosomal structural alterations in single cells by SNP arrays: a systematic survey of amplification bias and optimized workflow. PLoS One (2007) 1.25
Genetic variation of melatonin productivity in laboratory mice under domestication. Proc Natl Acad Sci U S A (2010) 1.24
Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC Cell Biol (2011) 1.23
Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry (2007) 1.22
A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry (2005) 1.20
Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia. J Psychiatr Res (2006) 1.18
DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Med (2012) 1.18
Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins. J Neurosci (2002) 1.15
Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res (2010) 1.14
The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J Biol Chem (2007) 1.14
Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet (2005) 1.11
A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol Psychiatry (2005) 1.11
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 1.11
Genome-wide association study of panic disorder in the Japanese population. J Hum Genet (2009) 1.09
DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet (2013) 1.08
Tracing the silhouette of individual cells in S/G2/M phases with fluorescence. Chem Biol (2008) 1.08
Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci (2004) 1.08
Human brain structural change related to acute single exposure to sarin. Ann Neurol (2007) 1.07
What causes seasonality of birth in schizophrenia? Neurosci Res (2004) 1.07
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet (2006) 1.07
Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist (2006) 1.05
Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res (2002) 1.05
Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet (2004) 1.04
Genome-wide association study of schizophrenia in Japanese population. PLoS One (2011) 1.02
Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines. Epigenetics (2011) 1.02
Associations between psychotic-like experiences and mental health status and other psychopathologies among Japanese early teens. Schizophr Res (2008) 1.02
Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res (2005) 1.01
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry (2005) 1.01
Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav Brain Funct (2006) 1.01
Volume reduction and altered sulco-gyral pattern of the orbitofrontal cortex in first-episode schizophrenia. Schizophr Res (2010) 1.01
Epigenetics in mood disorders. Environ Health Prev Med (2007) 1.00
Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol (2009) 0.99
Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res (2004) 0.99
Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry (2010) 0.99
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. J Hum Genet (2010) 0.98
Hypofrontality and microvascular dysregulation in remitted late-onset depression assessed by functional near-infrared spectroscopy. Neuroimage (2005) 0.98
Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. Genomics (2004) 0.98
XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells. J Neurochem (2006) 0.97
DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res (2013) 0.97
Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing. RNA (2005) 0.96
Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis. Schizophr Res (2011) 0.96
ERK-FosB signaling in dorsal MPOA neurons plays a major role in the initiation of parental behavior in mice. Mol Cell Neurosci (2007) 0.96
A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry (2012) 0.96
The correlation between unemployment and suicide rates in Japan between 1978 and 2004. Leg Med (Tokyo) (2007) 0.95
Variant GADL1 and response to lithium in bipolar I disorder. N Engl J Med (2014) 0.95
Epigenetic profiling in schizophrenia and major mental disorders. Neuropsychobiology (2009) 0.95
Functional polymorphisms of HSPA5: possible association with bipolar disorder. Biochem Biophys Res Commun (2005) 0.95
Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol (2008) 0.94
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. Am J Med Genet B Neuropsychiatr Genet (2006) 0.94
Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents. Neuropsychiatr Dis Treat (2012) 0.93
Knockdown of LIM15/DMC1 in the mushroom Coprinus cinereus by double-stranded RNA-mediated gene silencing. Microbiology (2005) 0.93
Contrasting quiescent G0 phase with mitotic cell cycling in the mouse immune system. PLoS One (2013) 0.93
Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res (2006) 0.92
Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions. Neuropsychopharmacology (2008) 0.92
Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci Res (2008) 0.91
Up-regulation of ADM and SEPX1 in the lymphoblastoid cells of patients in monozygotic twins discordant for schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2008) 0.91
Evaluation of whole genome amplification methods using postmortem brain samples. J Neurosci Methods (2007) 0.91
Intrasubject reproducibility of prefrontal cortex activities during a verbal fluency task over two repeated sessions using multi-channel near-infrared spectroscopy. Psychiatry Clin Neurosci (2009) 0.90
Replication of a genome-wide association study of panic disorder in a Japanese population. J Hum Genet (2009) 0.90
Failure to confirm CNVs as of aetiological significance in twin pairs discordant for schizophrenia. Twin Res Hum Genet (2010) 0.90
Functional, anatomical, and neurochemical differentiation of medial preoptic area subregions in relation to maternal behavior in the mouse. J Comp Neurol (2013) 0.89
Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res (2005) 0.89
Different hemodynamic response patterns in the prefrontal cortical sub-regions according to the clinical stages of psychosis. Schizophr Res (2011) 0.89
Support for relationship between serum cholinesterase and post-traumatic stress disorder; 5-year follow-ups of victims of the Tokyo subway sarin poisoning. Neurosci Res (2005) 0.89
Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study. Psychiatry Clin Neurosci (2004) 0.89
Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol (2013) 0.89
Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet (2009) 0.88
Classification of first-episode schizophrenia patients and healthy subjects by automated MRI measures of regional brain volume and cortical thickness. PLoS One (2011) 0.88
Psychotic-like experiences are associated with violent behavior in adolescents. Schizophr Res (2010) 0.88
Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS One (2009) 0.88
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One (2013) 0.88
Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol (2005) 0.87